UTIs are not listed as a recognised adverse effect in the Summary of Product Characteristics, and clinical trials have not identified them as a treatment-related safety concern
Yao L, Zhang M, Wang S et al (2025) Ascorbic acid relieves neuropathic pain and depressive behavior by reducing inflammation and activating antioxidant responses
Our results speak for themselves This program really works
Reported and produced by Sophie Braybrook, Samantha Everett, Helen Johnson, Ian Watkins and Girish Juneja
Entre los hallazgos ms destacados se encuentran nuevos resultados de ensayos clnicos en fase III, que muestran que algunos compuestos mimticos de GLP-1 como liraglutida, semaglutida y tirzepatida, ofrecen una eficacia comparable o incluso superior a la de medicamentos como Ozempic, sin generar efectos secundarios hepticos graves
E., Han, S